These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 25660949)
1. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy. Rei M; Pennington DJ; Silva-Santos B Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949 [TBL] [Abstract][Full Text] [Related]
2. Gamma-delta (γδ) T cells: friend or foe in cancer development? Zhao Y; Niu C; Cui J J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940 [TBL] [Abstract][Full Text] [Related]
3. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds. Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489 [TBL] [Abstract][Full Text] [Related]
4. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Gomes AQ; Martins DS; Silva-Santos B Cancer Res; 2010 Dec; 70(24):10024-7. PubMed ID: 21159627 [TBL] [Abstract][Full Text] [Related]
5. γδ T cells in cancer immunotherapy. Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside. Braza MS; Klein B Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882 [TBL] [Abstract][Full Text] [Related]
7. The expanding universe of regulatory T cell subsets in cancer. Gajewski TF Immunity; 2007 Aug; 27(2):185-7. PubMed ID: 17723212 [TBL] [Abstract][Full Text] [Related]
8. Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma. Devaud C; Rousseau B; Netzer S; Pitard V; Paroissin C; Khairallah C; Costet P; Moreau JF; Couillaud F; Dechanet-Merville J; Capone M Cancer Immunol Immunother; 2013 Jul; 62(7):1199-210. PubMed ID: 23619975 [TBL] [Abstract][Full Text] [Related]
9. γδ T cells as a potential tool in colon cancer immunotherapy. Ramutton T; Buccheri S; Dieli F; Todaro M; Stassi G; Meraviglia S Immunotherapy; 2014; 6(9):989-99. PubMed ID: 25341120 [TBL] [Abstract][Full Text] [Related]
10. γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity. Janssen A; Villacorta Hidalgo J; Beringer DX; van Dooremalen S; Fernando F; van Diest E; Terrizi AR; Bronsert P; Kock S; Schmitt-Gräff A; Werner M; Heise K; Follo M; Straetemans T; Sebestyen Z; Chudakov DM; Kasatskaya SA; Frenkel FE; Ravens S; Spierings E; Prinz I; Küppers R; Malkovsky M; Fisch P; Kuball J Cancer Immunol Res; 2020 Apr; 8(4):530-543. PubMed ID: 32019779 [TBL] [Abstract][Full Text] [Related]
11. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy. Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998 [TBL] [Abstract][Full Text] [Related]
12. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy]. Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756 [TBL] [Abstract][Full Text] [Related]
13. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting. Li Y; Li G; Zhang J; Wu X; Chen X Front Immunol; 2020; 11():619954. PubMed ID: 33664732 [TBL] [Abstract][Full Text] [Related]
14. Harnessing γδ T cells in anticancer immunotherapy. Hannani D; Ma Y; Yamazaki T; Déchanet-Merville J; Kroemer G; Zitvogel L Trends Immunol; 2012 May; 33(5):199-206. PubMed ID: 22364810 [TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212 [TBL] [Abstract][Full Text] [Related]
16. Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells. Oberg HH; Peipp M; Kellner C; Sebens S; Krause S; Petrick D; Adam-Klages S; Röcken C; Becker T; Vogel I; Weisner D; Freitag-Wolf S; Gramatzki M; Kabelitz D; Wesch D Cancer Res; 2014 Mar; 74(5):1349-60. PubMed ID: 24448235 [TBL] [Abstract][Full Text] [Related]
17. Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Rei M; Gonçalves-Sousa N; Lança T; Thompson RG; Mensurado S; Balkwill FR; Kulbe H; Pennington DJ; Silva-Santos B Proc Natl Acad Sci U S A; 2014 Aug; 111(34):E3562-70. PubMed ID: 25114209 [TBL] [Abstract][Full Text] [Related]
18. Phosphoantigens overcome human TCRVgamma9+ gammadelta Cell immunosuppression by TGF-beta: relevance for cancer immunotherapy. Capietto AH; Martinet L; Cendron D; Fruchon S; Pont F; Fournié JJ J Immunol; 2010 Jun; 184(12):6680-7. PubMed ID: 20483742 [TBL] [Abstract][Full Text] [Related]
19. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer. Liu Z; Guo B; Lopez RD J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829 [TBL] [Abstract][Full Text] [Related]
20. Immune Effects of γδ T Cells in Colorectal Cancer: A Review. Ma R; Yuan D; Guo Y; Yan R; Li K Front Immunol; 2020; 11():1600. PubMed ID: 33013819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]